Internal Medicine · Brooklyn, NY
NPI
1891803037
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
0
Hospital affiliations
7001 Avenue U
Brooklyn, NY, 11234
Phone (718) 531-3703
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.0M
44,956 services
Medicare patients, 2024
10,499
Average age 78
Drug cost, 2024
$5.8M
22,569 prescriptions
Company payments, 2025
$2,187
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott M Andes was code 99203 (office e&m - new), 5,883 times for 5,881 patients. In total Scott M Andes billed 44,956 services in 174 codes, and Medicare paid $3.0M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99203 Office E&M - New | Office | 5,883 | 5,881 | $65.38 | $385K |
| 99491 Chronic, Principal, and Transitional Care Management | Office | 5,340 | 2,062 | $75.63 | $404K |
| 99213 Office E&M - Established | Office | 4,496 | 2,774 | $57.08 | $257K |
| 99214 Office E&M - Established | Office | 4,051 | 2,260 | $95.26 | $386K |
| 99349 Home E&M - New and Established | Office | 2,950 | 943 | $113.25 | $334K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 2,538 | 791 | $56.46 | $143K |
| 99497 Care Management/Coordination | Office | 1,911 | 1,269 | $74.04 | $141K |
| 99204 Office E&M - New | Office | 1,891 | 1,891 | $115.28 | $218K |
| G3002 Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 1,390 | 920 | $73.46 | $102K |
| 99458 E&M - Miscellaneous | Office | 1,307 | 148 | $34.67 | $45K |
| 99457 E&M - Miscellaneous | Office | 995 | 180 | $42.62 | $42K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 720 | 720 | $149.75 | $108K |
| 36415 Venipuncture Blood Collection | Office | 592 | 359 | $8.65 | $5,121 |
| 99424 Chronic, Principal, and Transitional Care Management | Office | 576 | 290 | $73.75 | $42K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 561 | 278 | $42.89 | $24K |
By year: 2022 $26K for 424 services; 2023 $72K for 1,184 services; 2024 $3.0M for 44,956 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 592 | 359 | $8.65 | $5,121 |
| 87798 Infectious Agent Detection by DNA/RNA | 377 | 29 | $34.39 | $13K |
| 84100 Clinical Chemistry | 213 | 174 | $4.65 | $990 |
| 83615 Clinical Chemistry | 212 | 174 | $5.92 | $1,255 |
| 84550 Clinical Chemistry | 212 | 173 | $4.43 | $939 |
| 83735 Clinical Chemistry | 212 | 174 | $6.57 | $1,393 |
| 82977 Clinical Chemistry | 211 | 173 | $7.06 | $1,490 |
| 80053 Clinical Chemistry | 209 | 171 | $10.35 | $2,163 |
| 85025 Blood Count | 209 | 173 | $7.61 | $1,590 |
| 86141 Clinical Chemistry | 201 | 170 | $12.69 | $2,551 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott M Andes prescribed most often to Medicare patients was Diclofenac Sodium, with 1,114 prescriptions and refills. In total Scott M Andes wrote 22,569 Medicare prescriptions that cost $5.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Diclofenac Sodium Generic | 1,114 | 1,328 | 278 | $653K |
| Atorvastatin Calcium Generic | 617 | 1,011 | 137 | $3,658 |
| Amlodipine Besylate Generic | 582 | 1,055 | 145 | $2,544 |
| Rosuvastatin Calcium Generic | 573 | 809 | 122 | $4,279 |
| Metoprolol Succinate Generic | 547 | 759 | 114 | $4,989 |
| Mounjaro Tirzepatide | 480 | 557 | 71 | $568K |
| Gabapentin Generic | 470 | 608 | 107 | $3,404 |
| Ztlido Lidocaine | 441 | 502 | 127 | $182K |
| Omeprazole Generic | 434 | 573 | 102 | $2,636 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 380 | 429 | 75 | $11K |
| Metformin Hcl Generic | 355 | 568 | 78 | $14K |
| Linzess Linaclotide | 353 | 391 | 68 | $197K |
| Celecoxib Generic | 338 | 360 | 65 | $5,970 |
| Losartan Potassium Generic | 300 | 531 | 68 | $1,952 |
| Levothyroxine Sodium Generic | 294 | 515 | 68 | $2,271 |
Brand drugs: 5,689 claims; generic drugs: 16,628 claims; opioid claims: 116.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott M Andes $2,187 ($2,187 in general payments such as food, travel and fees) from 22 companies. The largest payer was Abbvie Inc. with $478.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 31 | $478 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 13 | $215 |
| Axsome Therapeutics, Inc. AXSM | 9 | $198 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $151 |
| Pfizer Inc. PFE | 12 | $144 |
| Amgen Inc. AMGN | 8 | $142 |
| Cumberland Pharmaceuticals, Inc. CPIX | 1 | $121 |
| Astellas Pharma US Inc 4503.T | 4 | $114 |
| Novo Nordisk Inc NVO | 5 | $101 |
| Esperion Therapeutics, Inc. ESPR | 4 | $97.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.